𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intravenous Iron Therapy and Risk for Progressive Loss of Kidney Function in Patients with Chronic Kidney Disease

✍ Scribed by Mansour, Wissam; Bissram, Melisha; Rosner, Mitchell H.

Book ID
120376094
Publisher
S. Karger AG
Year
2011
Tongue
English
Weight
140 KB
Volume
118
Category
Article
ISSN
0028-2766

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

FDA report: Ferumoxytol for intravenous
FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease
✍ Min Lu; Martin H. Cohen; Dwaine Rieves; Richard Pazdur πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 88 KB

## Abstract On June 30, 2009, the United States Food and Drug Administration (FDA) approved ferumoxytol (Ferahemeβ„’ injection, AMAG Pharmaceuticals), an iron‐containing product for intravenous (IV) administration, for the treatment of iron deficiency anemia in adult patients with chronic kidney dise